International Psoriasis Council

International Psoriasis Council
subscribe
5   What's New
Search
International Psoriasis Council
subscribe
Search

Advancing Knowledge. Improving Care.

Digital Health and Psoriasis

IMPROVING ACCESS TO EFFECTIVE TREATMENTS, TIMELY DIAGNOSIS, AND OPTIMAL CARE

Project Description

To date, digital health and telemedicine has been largely focused on “first contact visits.” Psoriasis presents unique challenges, including the need for long-term management. Digital health offers opportunities to develop novel approaches such as exploring artificial intelligence (AI) solutions and the personal management of psoriasis care. IPC convened a working group to establish a road map for how IPC can aid the development and implementation of digital health and telemedicine focused on psoriasis diagnosis and management. he digital health working group, chaired by Andrew Blauvelt and co-chaired by George Han, has completed a global consensus statement regarding telemedicine in psoriasis management, considering cultural and technological differences. Additional activities will include: defining best practices for using telemedicine in treating psoriasis, educating dermatologists on both the opportunities and limitations of telemedicine, and conducting research to understand better the barriers to care based on current reimbursement policies on a global level. 

Project Leaders

Andrew

Blauvelt

,

MD, MBA

Blauvelt Consulting, LLC

Annapolis

,

Maryland

,

United States

IPC Board Member
Bio

George

Han

,

MD, PhD

Zucker School of Medicine at Hofstra/Northwell and Icahn School of Medicine at Mount Sinai

New York

,

New York

,

United States

IPC Councilor
Bio

Working Group Members

  • Daniela Armijo, Chile
  • Kevin Cooper, United States
  • Lucas Galimany, Chile
  • Netsanet Gebeyehu, Ethiopia
  • Paolo Gisondi, Italy
  • Mohammad Huq, Bangladesh
  • Satveer Mahil, United Kingdom
  • Alexander Navarini, Switzerland
  • Lev Pavlovsky, Israel
  • Dharshini Sathishkumar, India
  • Ron Vender, Canada

View more resources on digital health.

MORE

ABSTRACT

During the past few decades, classical in‐person communication has been enriched by opportunities for telemedicine. We are in a learning healthcare environment that takes advantage of the opportunities of telemedicine and in‐person consultations, reconciling the individuality of the patient and his/her psoriasis. A working group of experts in telemedicine was installed by the International Psoriasis Council (IPC) to formulate the opportunities and limitations of telemedicine in the diagnosis and treatment of psoriasis. The working group formulated statements on various aspects of telemedicine according to the nominal group technique to reach a consensus on these statements and explore the variation of opinions. Thirty‐six statements regarding teledermatology and psoriasis were agreed upon by the IPC working group. The value and necessity for the implementation of teledermatology in dermatologic healthcare practices for psoriasis are essential. Management of psoriasis through teledermatology is feasible with a few exceptions. In this communication, the statements are presented and discussed in the context of the available literature, and finally, a call to action by IPC is formulated related to these statements.

Link to article

CLOSE
[thrive_leads id='12021']

Subscribe to the IPC Newsletter

We believe that psoriasis patients, no matter where they live in the world, no matter how complex their symptoms, should have access to the best care available to them. Please join us in making this possible.

Name(Required)

What's New

First-Line Biologics in Psoriasis: Evidence from the BADBIR Cohort Study

In this IPC commentary, Matias Maskin examines evidence from the BADBIR registry demonstrating that first-line biologic therapy in moderate to severe psoriasis leads to faster skin clearance, improved quality of life, and a lower risk of comorbidities. The analysis challenges traditional step-up approaches and supports earlier, patient-centered treatment strategies.

Read More »
Monday, April 27, 2026

Recent Advances in Psoriasis: A Year in Review

In this Take Ten with IPC video, Dr. Leandro Leite discusses the most recent advances in psoriasis over the last year (March 2025 – March 2026). Topics include new guidelines, research, and recent studies.

WATCH NOW

Monday, April 6, 2026